Patents by Inventor Martin Shea

Martin Shea has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cancer-linked genes as targets for chemotherapy
    Publication number: 20080025981
    Abstract: Cancer-linked gene sequences, and derived amino acid sequences, are disclosed along with methods for assaying for potential antitumor agents based on their modulation of the expression of these cancer-related genes. Also disclosed are antibodies that react with the disclosed polypeptides and methods of using the antibodies to treat cancerous conditions, such as using the antibody to target cancerous cells in vivo for purposes of delivering therapeutic agents thereto. Also described are methods of diagnosing cancer using the gene sequences as well as the polypeptide sequences.
    Type: Application
    Filed: November 15, 2006
    Publication date: January 31, 2008
    Inventors: Paul Young, Reinhard Ebner, Zoe Weaver, Jeffrey Strovel, Stephen Horrigan, Martin Shea, Bernd Weigle, Michael Rieger, Jennifer Rick, Colyn Cain
  • Cancer-linked gene as target for chemotherapy
    Publication number: 20050220798
    Abstract: Cancer-linked gene sequences, and derived amino acid sequences, are disclosed along with processes for assaying potential antitumor agents based an their modulation of the expression of these cancer-linked genes. Also disclosed are antibodies that react with the disclosed polypeptides and methods of using the antibodies to treat cancerous conditions, such as by using the antibody to target cancerous cells in vivo for purposes of delivering therapeutic agents thereto. Also described are methods of diagnosing using the gene sequences.
    Type: Application
    Filed: June 4, 2003
    Publication date: October 6, 2005
    Inventors: Reinhard Ebner, Martin Shea